title: Pharmacist development and use of antiemetic protocols.
authors.forename: M
authors.initials: M
authors.lastname: Favier
authors.forename: F
authors.initials: F
authors.lastname: de Cazanove
authors.forename: F
authors.initials: F
authors.lastname: Bressolle
authors.forename: F
authors.initials: F
authors.lastname: Bons
authors.forename: E
authors.initials: E
authors.lastname: Coste
authors.forename: M
authors.initials: M
authors.lastname: Galtier
mesh_terms: D000932:Antiemetics / Q000191:economics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D002985:Clinical Protocols; D005602:France; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D017294:Ondansetron / Q000191:economics / Q000627:therapeutic use; D010595:Pharmacists; D010607:Pharmacy Service, Hospital
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents; D017294:Ondansetron